- জেনেরিক নাম
- Rivaroxaban
- শক্তি
- 2.5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
৳ ৭.৮৪ ৳ ৮ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
Rivaban 2.5 হলো Rivaroxaban-এর একটি ব্র্যান্ড, শক্তি ২.৫ mg, ট্যাবলেট আকারে। এই ব্র্যান্ডের প্রস্তুতকারক Advanced Chemical Industries PLC। তালিকাভুক্ত প্রতি ইউনিটের দাম ৮ টাকা। Rivaban 2.5-এর সাথে Rivaroxaban-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Rivaroxaban-এর ১৯টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১টি। সবচেয়ে কম দাম Rivadel 2.5 Tablet-এর, প্রতি ইউনিট ৳ ৫।
Rivaban 2.5 is an oral anticoagulant tablet containing 2.5 mg of rivaroxaban. It works by blocking factor Xa, a substance in the blood clotting process, which lowers the formation of thrombin and helps reduce clot formation. Doctors prescribe it for adults after an acute coronary syndrome with raised cardiac biomarkers, alongside aspirin or aspirin with clopidogrel or ticlopidine. Because it affects clotting, bleeding is the main concern, and it should only be used under medical supervision. The dose and course are set by the doctor.
Rivaban 2.5 is used in adults after an acute coronary syndrome where cardiac biomarkers are raised, to help prevent atherothrombotic events. It is given together with aspirin alone, or with aspirin plus clopidogrel or ticlopidine. It is an oral anticoagulant and is not meant for self-treatment. Ask the doctor whether it suits your condition and what other medicines you need to take with it.
Rivaban 2.5 is a tablet taken by mouth. The doctor decides the dose, how often to take it, and how long the course lasts, and also which other medicines are taken alongside it. Follow the doctor's instructions exactly and do not change the dose yourself. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than adjusting it on your own.
The most common side effect of rivaroxaban is an increased chance of bleeding. Spinal or epidural hematoma can occur, and there is an increased risk of stroke after stopping the medicine in people with nonvalvular atrial fibrillation. Tell your doctor promptly about any unusual or prolonged bleeding. Ask your doctor or pharmacist about any other effects you notice while taking Rivaban 2.5.
Rivaban 2.5 is not for people with a known allergy to rivaroxaban or any ingredient of the tablet, or with active pathological bleeding. Stopping it early without other adequate anticoagulation raises the risk of thrombotic events. Bleeding risk may be higher with bleeding disorders, uncontrolled severe high blood pressure, certain gastrointestinal diseases, vascular retinopathy, bronchiectasis, or a history of pulmonary bleeding. It is a pregnancy category C drug; safety in pregnancy and breastfeeding has not been established, so ask your doctor first.
Rivaroxaban is a pregnancy category C drug, and there are no adequate or well-controlled studies in pregnant women; dosing for pregnant women has not been established. It is not known whether it passes into human milk, and safety in breastfeeding women has not been established. Ask your doctor before use.
It is an oral anticoagulant tablet containing 2.5 mg rivaroxaban. It is used in adults after an acute coronary syndrome with raised cardiac biomarkers to help prevent atherothrombotic events, taken with aspirin alone or with aspirin plus clopidogrel or ticlopidine. Your doctor will confirm whether it is suitable for you.
It is a tablet taken by mouth. The doctor decides the dose, how often it is taken, and how long the course lasts, as well as which other medicines you take with it. Follow the doctor's instructions exactly and do not change the dose yourself. Ask your doctor or pharmacist if anything is unclear.
Tell your doctor about any allergy to rivaroxaban or tablet ingredients, active bleeding, bleeding disorders, uncontrolled severe high blood pressure, gastrointestinal disease, vascular retinopathy, bronchiectasis, or a history of pulmonary bleeding. Also mention all other medicines you take, since some can raise bleeding risk or affect how the medicine works.
৳ ৭.৮৪ ৳ ৮ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a highly selective direct factor Xa inhibitor. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibits thrombin formation. Rivaroxaban does not inhibit thrombin (activated factor II) and no effects on platelets have been demonstrated.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban 2.5 mg:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Concomitant use with drugs that are combined P-gp and CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, erythromycin, fluconazole, diltiazem, verapamil, dronedarone) increases in Rivaroxaban exposure and pharmacodynamic effects (i.e., factor Xa inhibition and PT prolongation), that’s why should be avoided. Co-administration of Rivaroxaban with a combined P-gp and strong CYP3A4 inducer (e.g., rifampicin, phenytoin, carbamazepine) decreases the efficacy of Rivaroxaban and also should be avoided. The concomitant use of other drugs like anti-platelet agents, heparin, fibrinolytic therapy, NSAIDs may cause an increased risk of bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
It is contraindicated in patients with known hypersensitivity of Rivaroxaban or any of the excipients of the product. It is also contraindicated in patients with active pathological bleeding.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The most common side effects of Rivaroxaban have increased chance of bleeding, spinal or epidural hematoma and increased risk of stroke after discontinuation in nonvalvular atrial fibrillation.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Rivaroxaban is a pregnancy category C drug. There are no adequate or well-controlled studies of Rivaroxaban in pregnant women, and dosing for pregnant women has not been established. It is not known if Rivaroxaban is excreted in human milk. The safety and efficacy of Rivaroxaban has not been established in breastfeeding women.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Early discontinuation of Rivaroxaban, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events. Rivaroxaban increases the risk of bleeding that can be fatal in presence of following risk factors- bleeding disorders, uncontrolled severe arterial hypertension, gastrointestinal disease (e.g., inflammatory bowel disease, oesophagitis, gastritis and gastroesophageal reflux disease), vascular retinopathy, bronchiectasis, history of pulmonary bleeding. Signs or symptoms of neurological impairment should be monitored in case of neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture as epidural or spinal hematoma can occur. Rivaroxaban is not recommended in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Overdose of Rivaroxaban may lead to hemorrhage. Rivaroxaban systemic exposure is not further increased at single doses >50 mg due to limited absorption. A specific antidote for Rivaroxaban is not available. The use of activated charcoal to reduce absorption in case of Rivaroxaban overdose may be considered. Partial reversal of laboratory anticoagulation parameters may be achieved with use of plasma products.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a cool (below 30°C) & dry place protected from light. Keep away from the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।